Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 1 hour 12 min ago

Takeda Announces Appointment of New President of U.S. Business Unit

Mon, 04/13/2015 - 15:31
DEERFIELD, Ill., April 13, 2015 -- (Healthcare Sales & Marketing Network) -- Takeda Pharmaceutical Company Limited ("Takeda"), and Takeda's wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. ("TPUSA") announced today that Ram...
Biopharmaceuticals, Personnel
Takeda Pharmaceutical

Depomed Announces Gralise(R) ANDA Litigation Settlement Confirming Exclusivity to 2024 and Dismissing Appeal

Mon, 04/13/2015 - 15:27
NEWARK, Calif., April 13, 2015 -- (Healthcare Sales & Marketing Network) -- Depomed, Inc. (DEPO) today announced it has entered into a settlement agreement with Actavis, Inc. in Depomed's patent infringement litigation related to Actavis's Abbreviated New...
Biopharmaceuticals, Generics, Litigation
Depomed, Actavis, Gralise, gabapentin

Radius Health Today Announced That it Has Appointed Brent Hatzis-Schoch as Senior Vice President and General Counsel

Fri, 04/10/2015 - 14:18
WALTHAM, Mass., April 10, 2015 -- (Healthcare Sales & Marketing Network) -- Radius Health, Inc. (RDUS) a science-driven biopharmaceutical company developing new therapeutics for patients with advanced osteoporosis as well as other serious endocrine-mediate...
Biopharmaceuticals, Personnel
Radius Health

Horizon Pharma plc Receives FDA Fast Track Designation for ACTIMMUNE(R) in the Treatment of Friedreich's Ataxia

Fri, 04/10/2015 - 13:22
DUBLIN, IRELAND--(Healthcare Sales & Marketing Network) - Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated products that a...
Biopharmaceuticals, Neurology, FDA
Horizon Pharma, ACTIMMUNE, Friedreich's Ataxia

Caris Life Sciences Appoints Dr. David Spetzler Chief Scientific Officer

Thu, 04/09/2015 - 12:23
Executive Appointment Complements Strategic Alignment to Further Develop and Expand Carisome TOP Platform IRVING, Texas, April 9, 2015 -- (Healthcare Sales & Marketing Network) -- Caris Life Sciences®, a leading biotechnology company focused on ful...
Biopharmaceuticals, Personnel
Caris Life Sciences, Carisome TOP

PTC Therapeutics Names Eric Pauwels SVP and General Manager Commercial Operations, Americas

Wed, 04/08/2015 - 15:30
SOUTH PLAINFIELD, N.J., April 8, 2015 -- (Healthcare Sales & Marketing Network) -- PTC Therapeutics, Inc. (PTCT), today announced the appointment of Eric Pauwels as Senior Vice President and General Manager Commercial Operations, Americas. Eric will be re...
Biopharmaceuticals, Personnel
PTC Therapeutics, Translarna

Alzheon Announces $10 Million Series A Financing

Wed, 04/08/2015 - 13:48
Funding to Advance ALZ-801 Toward a Pivotal Clinical Study in Alzheimer’s Disease FRAMINGHAM, Mass.--(Healthcare Sales & Marketing Network)--Alzheon, Inc., a clinical-stage biopharmaceutical company focused on brain health, memory and aging, announced t...
Biopharmaceuticals, Neurology
Alzheon, Alzheimer’s disease

ArmaGen Announces FDA Acceptance of IND Application for AGT-181 for the Treatment of Hurler Syndrome

Wed, 04/08/2015 - 13:39
CALABASAS, Calif., April 8, 2015 -- (Healthcare Sales & Marketing Network) -- ArmaGen, Inc., a privately held biotechnology company focused on developing novel therapies to treat severe neurological disorders, announced today that the Investigational New ...
Biopharmaceuticals, Neurology
ArmaGen, AGT-181, Hurler syndrome

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong